University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 16 of 25

COMPLETED Phase 1

Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome

NCT00892190

COMPLETED NA

Effect of Weight Loss on Cardiovascular Disease Risk Factors in Obese Women

NCT01353001

COMPLETED NA

Wheeled Mobility for Preventing Pressure Ulcers

NCT01275313

COMPLETED NA

Program Reinforcement Impacts Self Management (PRISM)

NCT01343056

TERMINATED

Effect of Concentrating Endogenous Stromal Cells in the Fat Graft

NCT01564524

TERMINATED NA

Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)

NCT01252329

COMPLETED Phase 2

Effect of Simethicone on Eustachian Tube Dysfunction

NCT01312038

COMPLETED Phase 2

Single- vs. Double-Bundle ACL Reconstruction

NCT01319409

COMPLETED NA

Connect to Quit for Smoking

NCT01299896

COMPLETED Phase 4

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

NCT01326533

COMPLETED Phase 1

Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury

NCT01322009

TERMINATED NA

Lumbar Drain After Endoscopic Surgery of the Skull Base

NCT03163134

COMPLETED NA

Aging Successfully With Pain

NCT01405716

COMPLETED Phase 2

Thinking, Walking Outcomes by Type of Exercise

NCT01635348

COMPLETED NA

Computer-Assisted Provision of Reproductive Health Care

NCT00829517

COMPLETED

Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy

NCT01485419

COMPLETED

The Healing Context in Complementary and Alternative Medicine (CAM): Instrument Development and Initial Validation

NCT01266304

COMPLETED NA

Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement

NCT01361178

TERMINATED Phase 1

A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures

NCT01564407

COMPLETED NA

Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)

NCT01292876

COMPLETED

Hepatitis B Research Network Pediatric Cohort Study (HBRN)

NCT01263600

COMPLETED

Hepatitis B Research Network Adult Cohort Study

NCT01263587

COMPLETED Phase 2

Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial

NCT01187771

COMPLETED

Specimen Collection Study for Development and Validation of Laboratory Procedures

NCT01236027

COMPLETED

Acceptability Study of Vaginal Films for HIV Prevention

NCT01231763

COMPLETED NA

Chiropractic Manipulation and Medical Care for Low Back Pain

NCT01211613

COMPLETED

Brain Activation During Accommodation to Painful Stimulation With FMRI

NCT01242540

COMPLETED NA

Family Based Interpersonal Psychotherapy (FB-IPT) for Depressed Preadolescents

NCT02054312

COMPLETED NA

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

NCT01184079

COMPLETED

Osteogenic Profiling of Normal Calvarial Bone

NCT02933359

COMPLETED NA

From Innovation to Solutions: Childhood Influenza Vaccination Planning

NCT01664793

TERMINATED Phase 1

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

NCT01144169

COMPLETED NA

Diabetes Prevention Translation: the Healthy Lifestyle Project

NCT01050205

COMPLETED Phase 2

Innovative Approaches to Diet, Exercise and Activity

NCT01131871

COMPLETED Phase 2

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

NCT01031381

COMPLETED Phase 1

Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia

NCT01292577

COMPLETED NA

Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis

NCT01222273

COMPLETED Phase 1

Hybrid Model of Vocal Inflammation and Tissue Mobilization

NCT01197339

COMPLETED Phase 1

Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis

NCT01223183

COMPLETED NA

Stress Management Intervention for Mothers of Children With Cancer

NCT02022449

COMPLETED

Radiation Dose of Pediatric Patients During Ureteroscopy

NCT02895711

COMPLETED NA

Influenza and Text Messaging in Pregnancy

NCT01248520

TERMINATED Phase 2

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

NCT00932152

COMPLETED NA

High Protein Intake to Decrease Emesis and Promote Patient Satisfaction in Labor

NCT01414478

COMPLETED NA

Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

NCT00902798

COMPLETED NA

Pilot Study of a Text Message Platform to Reduce Risky Drinking in Young Adults

NCT01197352

COMPLETED Phase 3

Virtual Continuity and Its Impact on Complex Hospitalized Patients' Care

NCT01397253

COMPLETED NA

Comparison Between Epidural and Bilateral Paravertebral Blocks in Liver Resection

NCT01407666

COMPLETED NA

Physical Activity in Overweight Girls: Implications for Reversing Risk Factors for Type 2 Diabetes

NCT01323088

COMPLETED Early Phase 1

Cocaine Use Disorder and Cortical Dopamine

NCT03349606

← Previous Page 16 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.